5 Star
generic cialis http://genericalis.com/ buy online.
.

Men given just months or weeks to live after being diagnosed with prostate cancer are surviving for more than a year thanks to a breakthrough in immunotherapy treatment, a trial has shown.

Almost 40% of patients who spent 12 months on the drug pembrolizumab - known as a "checkpoint inhibitor" - as part of a new study were still alive and one in 10 had not seen the cancer grow.

The 258 men with advanced prostate cancer were treated with the drug as part of a trial led by a team at the Institute of Cancer Research (ICR) in London and the Royal Marsden NHS Foundation Trust.

The results - which are to be presented at the American Society of Clinical Oncology annual meeting in Chicago - have been lauded as "amazing".

:: http://www.cialij.com/?what.are.some.side.effects.of.cialis

http://zolftgenhuf.com/?where.to.buy.zoloft.london